Remove Drug Development Remove Health science Remove Life Science
article thumbnail

Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)

Digital Health Global

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Its mission is to improve patient outcomes, train the next generation of scientists and clinicians, and enhance the competitiveness of the UK life sciences sector.